COVID-19: Optimising heart failure management in the patient’s home

Michael Kiernan Physicians recognised the importance of remote management for heart failure patients long before the COVID-19 pandemic. However, the current situation has heightened the urgency of the transition for this vulnerable population. In this commentary, Michael Kiernan reviews how remote monitoring of heart failure patients could help to reduce heart failure [...]

2020-04-16T13:55:20+00:00April 16th, 2020|Tags: , , |

First patients enrolled in PROACTIVE-HF trial of Cordella pulmonary artery pressure sensor system

Cordella Endotronix has announced the enrolment of the first two patients in the PROACTIVE-HF trial. The trial is a premarket investigational device exempt (IDE) study evaluating the safety and efficacy of the Cordella pulmonary artery pressure sensor system (Cordella sensor) for the treatment of heart failure. The first two patients were successfully [...]

2020-02-27T13:19:12+00:00February 27th, 2020|Tags: , , |

Endotronix closes expanded Series D financing round of $70 Million

Cordella system Endotronix has announced the expansion of its Series D financing round, bringing the total for the round to $70 million. The expansion syndicate for the LSP-led round includes new investment from an additional unnamed medical device strategic investor as well as participation from existing investors, including Aperture Venture Partners, BioVentures [...]

2019-10-09T15:31:42+00:00October 9th, 2019|Tags: , , |

First patient enrolled in CE mark trial of Cordella pulmonary artery sensor system

A press release reports that the first patient has been enrolled in a prospective, multicentre trial (SIRONA II) of a pulmonary artery pressure sensor system (Cordella sensor, Endotronix), the aim of which is to valuate safety and efficacy of the system in support of its CE mark submission. Wilfried Mullens (Ziekenhuis Oost Limburg, Genk, [...]

2019-07-15T15:21:11+00:00July 15th, 2019|Tags: , |
Go to Top